GLP-1 series
Module 5 · Case-based
Avoiding Common GLP-1 Prescribing Mistakes
Six errors that drive denials and harm — indication mismatch, fast titration, missed contraindications, interactions, compounded use, and thin documentation.
11 slides · 15 minutes
Video coming soon
15-minute recorded module
What this module covers
- 01Why GLP-1 prescribing draws scrutiny
- 02Mistake 01: indication must match the approved use
- 03Mistake 02: respect the titration ladder
- 04Mistake 03: screen for contraindications and red flags
- 05Mistake 04: interactions, hypoglycemia and surgery
- 06Mistake 05: off-label, compounded and cosmetic use
- 07Mistake 06: build a complete prior-authorization packet
- 08Case files: the mistake and the fix
- 09Six checks before you sign off
Key takeaways
Align drug, indication and diagnosis codes before submission.
Hold and re-escalate at the prior dose after intolerance.
Complete documentation more than doubles first-pass approval.
Continue the series
Module 1
GLP-1–Based Therapies in Cardio-Oncology
Module 2
GLP-1 Receptor Agonist Therapy: The Complete Briefing
Module 3
Obesity, Cardiometabolic Health & GLP-1 Therapies
Educational information only. It does not replace advice from your oncology or primary care team, and no treatment decision should be made from this module alone.